Vivus sanus, UAB - financials and debts

Company age: 15 y. 0 mo.

Update

Vivus sanus - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 789,587 1,020,695 1,284,133 1,746,762 2,196,089 2,652,958 3,005,988 2,816,482
Profit before tax 2,420 64,580 233,567 425,113 633,881 749,560 985,360 572,293
Net profit 2,236 59,734 209,937 379,961 568,164 675,405 943,918 480,072
Equity 358,943 418,677 627,272 1,007,232 999,291 1,662,930 2,606,847 1,439,860
Liabilities 402,528 324,700 258,738 372,972 305,759 391,909 276,895 366,889
Non-current assets 661,785 586,624 455,415 637,458 506,519 344,041 839,726 745,378
Current assets 98,413 155,669 429,851 741,799 797,995 1,709,767 2,043,097 1,057,158
Total assets 760,198 742,293 885,266 1,379,257 1,304,514 2,053,808 2,882,823 1,802,536
Taxes paid
STI taxes - - - - - 309,277 361,139 573,475
Social insurance contributions - - - - - 262,336 299,253 346,912
Financial indicators
Revenue change y/y +7.9% +29.3% +25.8% +36.0% +25.7% +20.8% +13.3% -6.3%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 0.3% 8.0% 23.7% 27.5% 43.6% 32.9% 32.7% 26.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 0.6% 14.3% 33.5% 37.7% 56.9% 40.6% 36.2% 33.3%
Profit margin Net profit margin. Shows the overall profitability of the company. 0.3% 5.9% 16.3% 21.8% 25.9% 25.5% 31.4% 17.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 0.3% 6.3% 18.2% 24.3% 28.9% 28.3% 32.8% 20.3%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.1 0.8 0.4 0.4 0.3 0.2 0.1 0.3
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 18,186 17,523 20,684 26,104 30,152 32,854 34,420 33,038

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Vivus sanus - Social security debts

From To Debt, €
2025-03-18 2025-03-25 155.97
2025-02-18 2025-03-13 58.75
2023-03-16 2023-03-16 18924.72
2021-12-16 2021-12-19 12566.31

Vivus sanus - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Vivus sanus, UAB (company code 302671296) is a Private Limited Liability Company operating in medical specialists activities. In 2025, the company generated revenue of €2.82M and net profit of €480.1K, with a profit margin of 17.0%. Revenue decreased by 6.3% year on year, although it remained 6.2% higher than two years earlier. The 2023-2025 trend shows revenue rising from €2.65M in 2023 to €3.01M in 2024, before easing in 2025, while net profit increased from €675.4K in 2023 to €943.9K in 2024 and then declined to €480.1K in 2025. At the end of 2025, total assets stood at €1.80M, equity at €1.44M and liabilities at €366.9K. Long-term assets amounted to €745.4K and short-term assets to €1.06M. Financial structure remained solid, with an equity ratio of 79.9% and debt-to-equity of 0.25. Return on equity was 33.3% and return on assets 26.6%, while asset turnover reached 1.56x. Revenue per employee was €33.1K and profit per employee €5.6K.